Older mothers and the risk of stillbirth
-
Authors list
Dr Samantha Lean, Katie Stephens, Dr Rebecca Jones, Professor Alexander Heazell, Dr Mark Dilworth
-
Research centre
Women who become pregnant when they are over 35 are more at risk of giving birth to babies that are too small, or stillborn. We’re not sure why older mothers are more likely to suffer stillbirth, but we think it might be to do with the placenta.
Older women often have placentas that aren’t working as well as they should. If we can understand how this might cause stillbirth, we can try and create treatments that stop stillbirths by helping women to have healthier placentas.
Tommy’s are supporting the Manchester Advanced Maternal age study (MAMAS) to try and find answers. Researchers are studying over 560 women of different ages from across the UK. We have confirmed that women over 35 are more at risk of pregnancy complications, and that this risk is even higher for women over 40.
Scientists took samples of the women’s blood and placentas, as well as collecting information about the women’s lifestyles. They found that placentas from older women showed signs that they were aging faster than those from younger women. The cells in the placenta were also under more stress: they were less able to repair damage, and showed signs of inflammation. We think that these factors might stop them working normally, meaning it is more difficult for the baby to get the oxygen and nutrients that it needs.
Meanwhile, researchers also looked at mice to see if age is related to stillbirth. Studying mice can be helpful, as it means scientists don’t have to worry about the complicated differences in lifestyles that humans have. Again, older mice had more stillbirths, and a larger number of babies that didn’t grow properly. They also had heavier placentas that were less able to transport nutrients to their growing babies.
Scientists are currently treating older pregnant mice with a substance called melatonin. This is a hormone that normally plays a part in controlling our sleeping patterns. Early findings from this are promising: so far, there have been no stillbirths in mice who were given melatonin. There are also signs that their babies are growing more, and their placentas working better.
Going forward, we will carry on looking at melatonin, along with other substances, to see if they can be used to prevent stillbirths. Results so far suggest that these could be promising ways of preventing stillbirth in older mothers.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news. If you're interested in being kept updated about our research and news from Tommy's, click here.
This study is fully funded by Tommy's and takes place in a Tommy's centre
Read more on this topic
-
Research into stillbirth
When a baby dies after 24 weeks of gestation, it is called a stillbirth. Nearly 3000 families a year get the devastating news that their baby is not alive. Our research is helping to change this. -
Preventing stillbirth: the role of the immune system in rejecting the placenta
Tommy’s are studying chronic histiocytic intervillositis, which causes the immune system to reject the placenta, leading to stillbirth or miscarriage. -
Understanding how the womb lining matures during pre-eclampsia
Pre-eclampsia can lead to health problems and sometimes stillbirth, but we don’t know enough about what causes it. Our researchers are studying how the lining of the womb develops during early pregnancy. This could reveal new ways to prevent pre-eclampsia and reduce the risk of stillbirth. -
The AFFIRM trial for prevention of stillbirth
Researchers supported by Tommy’s are looking at whether a package of care and resources for pregnant women can help stop stillbirths. -
Stillbirth and fetal free haemoglobin
Researchers supported by Tommy’s have found that the substance that usually carries oxygen around our blood may have harmful effects on the baby when it escapes from red blood cells. -
Diabetes, fetal growth and stillbirth
Women suffering from type 1 or type 2 diabetes are more likely to suffer from stillbirths. We want to help people with diabetes to have healthy pregnancies. -
ReMIT-2 – a feasibility study for spotting the early signs of complications
We need better ways to spot the early signs of pregnancy complications. The ReMIT-2 study laid the foundations for a large clinical trial of a blood test which could predict which women need urgent care to prevent stillbirth. -
Can low levels of taurine make stillbirth more likely?
Tommy’s researchers are looking at how the lack of an important nutrient might harm the placenta during pregnancy, putting women at a higher risk of stillbirth. -
Homing peptides: targeting drugs to the placenta
Drugs which could help prevent pregnancy complications can’t reach the placenta effectively. Tommy’s researchers are making use of ‘homing peptides’ to deliver drugs directly to the placenta. This work could help to prevent pregnancy complications and stillbirth. -
Can steroid injections improve blood flow to babies at risk of stillbirth?
Finding out whether steroids can improve the blood flow through the placenta -
Older mothers and the ageing placenta
Consistent with ageing, the placenta in older mothers does not work as effectively. Researchers supported by Tommy’s are investigating why this happens. -
Viagra: is it an effective treatment for stillbirth (STRIDER)
Viagra works by increasing blood flow. Fetal growth restriction is often caused by poor flow of blood through the placenta. This trial is looking at whether Viagra is effective in increasing blood flow to the baby.